16.08.2017

MagForce AG publishes Directors' Dealings

download PDF

 

16.08.2017

MagForce AG publishes Directors' Dealings

download PDF

 

14.08.2017

MagForce AG publishes Directors' Dealings

download PDF

 

10.08.2017

MagForce AG announces positive results of 2017 Annual General Meeting

Berlin, Germany, and Nevada, USA, August 10, 2017 – MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, held its Annual General Meeting in Berlin today. The Annual General Meeting approved all resolution ...

 

08.08.2017

Investment Plan for Europe: EIB backs German cancer therapy developer MagForce with up to EUR 35m

Patients who suffer from the most aggressive type of brain cancer, glioblastoma, will soon have broader access to a new form of treatment thanks to financing by the European Investment Bank (EIB). The EIB and German medical device company MagForce, listed in the Scale segment of the Frankfurt Stock ...